gastric cancer
FDA Approves Keytruda-Herceptin Combination for HER2-Positive Gastric, Gastroesophageal Cancer
The agency granted accelerated approval to Merck's pembrolizumab plus Herceptin and chemotherapy for patients with advanced, HER2-positive gastric cancer.
FDA Expert Panel Votes Against Keytruda Accelerated Approval for PD-L1-Positive Gastric Cancer
The ODAC voted to remove the accelerated approval due to the absence of demonstrated overall survival benefit in confirmatory clinical trials.
Transcenta Begins Phase I Trial of Anti-Claudin18.2 Drug in Gastric Cancer
The firm is evaluating TST001 with chemotherapy as a first-line treatment for unresectable or metastatic gastric cancer.
Flagship Biosciences, Leap Therapeutics Partner on Biomarker Screening for DKN-01 Clinical Trial
Flagship will use its RNAscope assay and image analysis to screen advanced gastric and gastroesophageal cancer patients for elevated DKK1 RNA expression.
Theseus Pharmaceuticals Emerges from Stealth Mode, Raises $100M in Series B Funding
The company's pipeline includes a KIT inhibitor that will move into clinical studies this year and an EGFR inhibitor in preclinical studies.
Nov 4, 2020